U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection: Updated Version. Geneva: World Health Organization; 2016 Apr.

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection

Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection: Updated Version.

Show details

Appendix 6Summary of declared interests

ParticipantsDeclared interestsDeclared amountLevel of participation
Isabelle Andrieux-MeyerPersonal: None
Institutional: None
Full
Evaldo Stanislau Affonso AraújoPersonal: Advisory board meeting and clinical trial for Janssen, conference registration and travel support by AbbvieUS$3000Full
Manal El-SayedPersonal: Travel support from MSD and Roche
Institutional: None
US$0Full
Charles GorePersonal: None
Institutional: President of World Hepatitis Alliance that receives grants and other support from BMS, Boehringer Ingelheim, Janssen, Roche, Roche diagnostics, Merck, GSK, Gilead, AbbVie, Abbott, Achillion, Bayer, Novartis
not specified;Restricted
Saeed Sadiq Hamid (Chair)Personal: Travel support from Gilead
Institutional: None
US$0Full
Karine LacombePersonal: Advisory board Gilead, BMS Research grant GileadUS$3000, US$2000Full
Olufunmilay LesiPersonal: None
Institutional: None
Full
Niklas LuhmannPersonal: None
Institutional: None
Full
David R. NelsonPersonal: None
Institutional: Research support by Abbvie, BMS, Genentech, Gilead, Janssen, Merck
Full
Francesco NegroPersonal: Consulting and advisory board for Janssen-Cilag, Gilead, MSD, BMS and AbbVie. Travel support to meeting by Janssen and Gilead.
Institutional: Gilead
US$5,000-10,000Restricted
Ponciano OcamaPersonal: Served on Abbvie advisory board, for a meeting in Cape Town, South Africa, November 28 and 29th, 2014US$1,500Full
Baatarkhuu OidovPersonal: None
Institutional: None
Full
Rockstroh, JürgenPersonal: Consulting in advisory board for Abbvie, Bionor, BMS, Gilead, Janssen, Merck, ViiV
Institutional: Research grant for immunology in acute HCV by NEAT, Research grant for acute HCV cohort by NEAT-ID
>US$5,000Restricted
Khwairakpam Giten SinghPersonal: None
Institutional: None
Full
Tracy SwanPersonal: None
Institutional: employer (a non-profit) accepts unrestriced grants from pharmaceutical companies.
Full
Lynn TaylorPersonal: None
Institutional: Research support by Gilead
Full
Emma ThomsonPersonal: None
Institutional: WELLCOME TRUST and MRC as principal investigator at Glasgow university, independent research funding
Full
Lai WeiPersonal: Abbvie, BMS, Gilead
Institutional: Research grant by BMS
<US$2000Full
Roger Chou (methodologist)Personal: None
Institutional: None
Full
Copyright © World Health Organization 2016.

All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: tni.ohw@sredrokoob).

Requests for permission to reproduce or translate WHO publications – whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html).

Bookshelf ID: NBK362929

Views

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...